我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

外源性磷酸肌酸对缺血豚鼠心室肌细胞L型钙通道电流的影响

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2010年第2期
页码:
168-171,175
栏目:
基础研究
出版日期:
2010-03-04

文章信息/Info

Title:
Effect of exogenous phosphocreatine on L-type calcium current in ischemic ventricular myocytes
作者:
时向民1李天德2王玉堂2单兆亮2杨庭树1
解放军总医院:1.南楼心内科,2.普通心内科,北京 100853
Author(s):
Shi Xiang-min1 Li Tian-de1 Wang Yu-tang2 Shan Zhao-liang2 Yang Ting-shu1
1.Cardiology Department, South Building, 2.Department of Cardiology, General Hospital of PLA, Beijing 100853, China
关键词:
豚鼠膜片钳 L型钙电流缺血磷酸肌酸
Keywords:
guinea pig patch clamp L-type calcium current ischemia heart failure phosphocreatine
分类号:
R542.2;R331.38
DOI:
-
文献标识码:
A
摘要:
目的: 观察不同浓度外源性磷酸肌酸(exogenous phosphocreatine,PCr)对豚鼠缺血心室肌细胞L型钙通道(ICa·L)电流的影响,探讨其治疗缺血性心力衰竭的电生理学机制。方法: 单个心室肌细胞经酶解从豚鼠左心室获得,采用膜片钳全细胞模式记录ICa·L电流,通过灌注模拟缺血液并充以95%N2+5%CO2的混合气体建立缺血模型,将PCr加入模拟缺血液中分别配成5,10,20,30 mmol/L浓度。将细胞分成6组,分别予模拟缺血液,含有5,10,20,30 mmol/L浓度PCr的模拟缺血液,台氏液灌流,后者充以95%O2+5%CO2的混合气体。10 min后记录各组的峰电流及电流密度。结果: 与台氏液组相比,模拟缺血液组ICa·L峰电流密度降低(80.6±5.2)%(P<0.05),含有5,10,20,30 mmol/L浓度PCr的模拟缺血液组ICa·L峰电流密度分别降低(53.8±6.7)%(P<0.05);(41.8±8.2)%(P<0.05);(38.1±7.4)%(P<0.05);(36.6±9.7)%(P<0.05)。10,20,30 mmol/L3种浓度对ICa·L峰电流密度的影响无统计学差别。结论: PCr能明显增加缺血时受抑制的ICa·L峰电流及电流密度,这可能是其治疗缺血性心力衰竭的电生理学机制。PCr在低浓度 (0~10 mmol/L)对ICa·L电流及电流密度的影响呈现明显的量效关系,浓度大于10 mmol/L量效关系不明显。
Abstract:
AIM: To explore the effect of exogenous phosphocreatine (PCr) with different concentration on L-type calcium (ICa·L) current in ischemic ventricular myocytes of guinea pig and to investigate its underlying electrophysiological mechanism for the treatment of ischemic heart failure. METHODS: Ventricular myocytes were isolated enzymatically from left ventricular of guinea pig. Peak ICa·L current were recorded using patch clamp techniques in the whole-cell configuration when myocytes had been superfused with normal Tyrode solution, simple ischemic solution, ischemic solution containing PCr with different concentration of 5, 10, 20, 30 mmol/L for 10 min, respectively. RESULTS: Peak ICa·L current density of myocytes superfused with simple simulated ischemic solution was remarkably inhibited by (80.6±5.2)% compared with myocytes superfused with normal Tyrode solution (P<0.05). Ischemic solution containing PCr of 5, 10, 20, 30mmol/L inhibited Peak ICa·L current density by (53.8±6.7)%(P<0.05); (41.8±8.2)%(P<0.05); (38.1±7.4)%(P<0.05); (36.6±9.7)% (P<0.05), respectively. There was no statistical significance among PCr of 10, 20, 30 mmol/L. CONCLUSION: PCr could reverse the inhibition of ICa·L current under ischemic condition, which could be the ionic basis for the treatment of ischemic heart failure. 0-10 mmol/L PCr exerted a significant dose-effect relationship, which no longer existed as concentration >10 mmol/L.

参考文献/References

[1] Liu Q, Robert L. Stimulation of cardiac L-type calcium channels by extracellular ATP[J]. Am J Physiol Cell Physiol, 2001, 280(5):C1107-C1113.

[2] Soball S, Conrad A, Eistert A, et al. Uptake of creatine phosphate into heart mitochondria: A leak in the creatine shuttle[J]. Biochem Biophys Acta, 1997, 1320(1):27-33.

[3] Ferraro S, Codella C, Palumbo F, et al. Hemodynamic effects of creatine phosphate in patients with congestive heart failure: a double-blind comparison trial versus placebo[J]. Clin Cardiol, 1996, 19(9):699-703.

[4] Hamil OP. Twenty odd years of stretch-sensitive channels[J]. Pflugers Arch, 2006, 453(3):331-351.

[5] Treinys R, Jurevicius J. L-type Ca2+ channels in the heart: structure and regulation[J]. Medicina, 2008, 44(7):491-499.

[6] Kubalová Z. Inactivation of L-type calcium channels in cardiomyocytes. Experimental and theoretical approaches[J]. Gen Physiol Biophys, 2003, 22(4):441-454.

[7] Grzyb K, Skorkowski EF. Creatine kinase isoenzymes--characterization and functions in cell[J]. Postepy Biochem, 2008, 54(3):274-283.

[8] Conway M, Allis J, Ouwerkerk R, et al. Detection of phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31p magnetic resonance spectroscopy[J]. Lancet, 1991, 338(8773):973-976.

[9] Pastoris O, Dossena M, Vercesi L, et al. Biochemical changes induced in the myocardial cell during cardioplegic arrest supplemented with creatine phosphate[J]. J Cardiothorac Vasc Anesth, 1991, 5(5):475-480.

[10]Saks V, Dzhaliashvili I, Strumia E, et al. Molecular and cellular aspects of the cardioprotective mechanism of phosphocreatine[J]. Biokhimiia, 1992, 57(12):1763-1784.

备注/Memo

备注/Memo:
收稿日期:2009-5-27.通讯作者:王玉堂,主任医师,主要从事心脏电生理基础与临床研究Email:wyt301@sina.com 作者简介:时向民,副主任医师,博士Email:shixm301cardiac@hotmail.com
更新日期/Last Update: 2010-03-05